Skip to content
Screener

uniQure QURE Interest Expense

Interest Expense at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$21.51M-311%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$9K-52.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$49.03M-43.8%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.56M+411%
Regenxbio logo
RegenxbioRGNX
$7.79M-29.1%
Opus Genetics logo
Opus GeneticsIRD
$69K

Segments

By segment

See full
Single Reportable$1.4M-23.0%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other expense(7,961)(2,185)(9,412)(4,144)
Loss from operations(52,203)(43,865)(97,923)(83,196)
Interest income5,0513,52410,2807,651
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)
Income tax expense(1,841)(425)(2,329)(921)

Item 1.Financial Statements

FAQ

What is uniQure's interest expense?
uniQure (QURE) reported interest expense of $14.37M in Q2 2026.
How has uniQure's interest expense changed year-over-year?
uniQure's interest expense decreased by 7.9% year-over-year, from $15.59M to $14.37M.
What is the long-term trend for uniQure's interest expense?
Over 4 years (2021 to 2025), uniQure's interest expense has grown at a 69.7% compound annual growth rate (CAGR), from $7.47M to $61.99M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about uniQure's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude